These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31281532)
1. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers. Yang X; Zhao J; Duan S; Hou X; Li X; Hu Z; Tang Z; Mo F; Lu X Theranostics; 2019; 9(14):4066-4083. PubMed ID: 31281532 [No Abstract] [Full Text] [Related]
2. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Xie S; Hou X; Yang W; Shi W; Yang X; Duan S; Mo F; Liu A; Wang W; Lu X Int J Nanomedicine; 2021; 16():6017-6034. PubMed ID: 34511903 [TBL] [Abstract][Full Text] [Related]
3. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses. He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421 [TBL] [Abstract][Full Text] [Related]
4. Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma. Duan S; Song M; He J; Zhou N; Zhou S; Zhao J; Fang Y; Yi P; Huang X; Luo G; Lai C; Yu X; Zhang Z; Xie Y; Zhao Y; Lu X J Biomed Nanotechnol; 2016 Apr; 12(4):700-9. PubMed ID: 27301196 [TBL] [Abstract][Full Text] [Related]
5. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells. Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma. Lai C; Yu X; Zhuo H; Zhou N; Xie Y; He J; Peng Y; Xie X; Luo G; Zhou S; Zhao Y; Lu X J Biomed Nanotechnol; 2014 Dec; 10(12):3576-89. PubMed ID: 26000371 [TBL] [Abstract][Full Text] [Related]
7. Adoptive CD8 Liu S; Liu H; Song X; Jiang A; Deng Y; Yang C; Sun D; Jiang K; Yang F; Zheng Y Nanoscale; 2021 Oct; 13(37):15789-15803. PubMed ID: 34528979 [TBL] [Abstract][Full Text] [Related]
8. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. Herrmann A; Priceman SJ; Swiderski P; Kujawski M; Xin H; Cherryholmes GA; Zhang W; Zhang C; Lahtz C; Kowolik C; Forman SJ; Kortylewski M; Yu H J Clin Invest; 2014 Jul; 124(7):2977-87. PubMed ID: 24892807 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity. Wang JY; Chen H; Dai SZ; Huang FY; Lin YY; Wang CC; Li L; Zheng WP; Tan GH J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256516 [TBL] [Abstract][Full Text] [Related]
10. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene. Huang Y; Huang Y; He J; Wang H; Luo Y; Li Y; Liu J; Zhong L; Zhao Y Biomaterials; 2019 Oct; 217():119231. PubMed ID: 31254933 [TBL] [Abstract][Full Text] [Related]
11. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909 [TBL] [Abstract][Full Text] [Related]
12. Recombinant Endoglin-Single-Chain Variable Fragment/ Induced Protein 10 Fusion Protein Potently Boosts the Anti-Tumor Efficacy of Adoptively Transferred TRP2-Specific CD8 Li Y; Yang X; Lu X; Peng Z; Lai C; Xie S; Wei S; Yao H; Ding Z; Zhao X; Liu A; Hou X; Mo F J Biomed Nanotechnol; 2020 Jul; 16(7):1119-1134. PubMed ID: 33308379 [TBL] [Abstract][Full Text] [Related]
13. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349 [TBL] [Abstract][Full Text] [Related]
14. A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models. Jiao JG; Li YN; Wang H; Liu Q; Cao JX; Bai RZ; Huang FY Dig Liver Dis; 2006 Aug; 38(8):578-87. PubMed ID: 16777500 [TBL] [Abstract][Full Text] [Related]
15. Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model. Wang X; Zhang FC; Zhao HY; Lu XL; Sun Y; Xiong ZY; Jiang XB Tumour Biol; 2014 Aug; 35(8):7781-91. PubMed ID: 24816916 [TBL] [Abstract][Full Text] [Related]
16. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells. Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772 [TBL] [Abstract][Full Text] [Related]
17. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386 [TBL] [Abstract][Full Text] [Related]
18. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808 [TBL] [Abstract][Full Text] [Related]
19. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide. Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352 [TBL] [Abstract][Full Text] [Related]
20. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8 Yin W; Song Y; Liu Q; Wu Y; He R Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]